These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32799659)

  • 1. Study and detection of potential markers for predicting metastasis into lymph nodes in prostate cancer.
    Papasotiriou I; Apostolou P; Ntanovasilis DA; Parsonidis P; Osmonov D; Jünemann KP
    Biomark Med; 2020 Oct; 14(14):1317-1327. PubMed ID: 32799659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant Myosin 1b Expression Promotes Cell Migration and Lymph Node Metastasis of HNSCC.
    Ohmura G; Tsujikawa T; Yaguchi T; Kawamura N; Mikami S; Sugiyama J; Nakamura K; Kobayashi A; Iwata T; Nakano H; Shimada T; Hisa Y; Kawakami Y
    Mol Cancer Res; 2015 Apr; 13(4):721-31. PubMed ID: 25421751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting metastatic prostate carcinoma in pelvic lymph nodes following neoadjuvant hormone therapy: the eyes have it!
    Kehr E; Masry P; Lis R; Loda M; Taplin ME; Hirsch MS
    Histopathology; 2016 Jan; 68(2):303-7. PubMed ID: 26018610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myosin 1C isoform A is a novel candidate diagnostic marker for prostate cancer.
    Saidova AA; Potashnikova DM; Tvorogova AV; Paklina OV; Veliev EI; Knyshinsky GV; Setdikova GR; Rotin DL; Maly IV; Hofmann WA; Vorobjev IA
    PLoS One; 2021; 16(5):e0251961. PubMed ID: 34019593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The loss of 5alpha-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis.
    Habib FK; Ross M; Bayne CW; Bollina P; Grigor K; Chapman K
    Clin Cancer Res; 2003 May; 9(5):1815-9. PubMed ID: 12738739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.
    Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED
    Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer: Molecular lymph node analysis for prognostication.
    Kelsey R
    Nat Rev Urol; 2018 Apr; 15(4):205. PubMed ID: 29508845
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate stem cell antigen is overexpressed in prostate cancer metastases.
    Lam JS; Yamashiro J; Shintaku IP; Vessella RL; Jenkins RB; Horvath S; Said JW; Reiter RE
    Clin Cancer Res; 2005 Apr; 11(7):2591-6. PubMed ID: 15814638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of 3D Lymph Node Mimetic for Studying Prostate Cancer Metastasis.
    Hakamivala A; Huang Y; Chang YF; Pan Z; Nair A; Hsieh JT; Tang L
    Adv Biosyst; 2019 Sep; 3(9):e1900019. PubMed ID: 32648652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of cytokeratin 20 and mucin 2 mRNA as metastasis markers in regional lymph nodes of colon cancer patients investigated by quantitative RT-PCR.
    Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R
    Int J Colorectal Dis; 2009 Mar; 24(3):261-8. PubMed ID: 19119477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF; Füllhase C; Boemans P; Fichtner J
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXB13 protein expression in metastatic lesions is a promising marker for prostate origin.
    Varinot J; Furudoï A; Drouin S; Phe V; Penna RR; Roupret M; Bitker MO; Cussenot O; Compérat E
    Virchows Arch; 2016 May; 468(5):619-22. PubMed ID: 26931741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
    Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
    Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective expression of myosin IC Isoform A in mouse and human cell lines and mouse prostate cancer tissues.
    Ihnatovych I; Sielski NL; Hofmann WA
    PLoS One; 2014; 9(9):e108609. PubMed ID: 25259793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine Differentiation in Metastatic Conventional Prostate Cancer Is Significantly Increased in Lymph Node Metastases Compared to the Primary Tumors.
    Genitsch V; Zlobec I; Seiler R; Thalmann GN; Fleischmann A
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival.
    Bostwick DG; Qian J; Pacelli A; Zincke H; Blute M; Bergstralh EJ; Slezak JM; Cheng L
    J Urol; 2002 Sep; 168(3):1204-11. PubMed ID: 12187268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and experimental role of ring finger protein 180 on lymph node metastasis and survival in gastric cancer.
    Deng J; Liang H; Zhang R; Hou Y; Liu Y; Ying G; Pan Y; Hao X
    Br J Surg; 2016 Mar; 103(4):407-16. PubMed ID: 26805552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.
    Ananias HJ; van den Heuvel MC; Helfrich W; de Jong IJ
    Prostate; 2009 Jul; 69(10):1101-8. PubMed ID: 19343734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
    Cai J; Shen G; Liu S; Meng Q
    Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.